Unknown

Dataset Information

0

Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines.


ABSTRACT: In Tuberculosis (TB), given the complexity of its transmission dynamics, observations of reduced epidemiological risk associated with preventive interventions can be difficult to translate into mechanistic interpretations. Specifically, in clinical trials of vaccine efficacy, a readout of protection against TB disease can be mapped to multiple dynamical mechanisms, an issue that has been overlooked so far. Here, we describe this limitation and its effect on model-based evaluations of vaccine impact. Furthermore, we propose a methodology to analyze efficacy trials that circumvents it, leveraging a combination of compartmental models and stochastic simulations. Using our approach, we can disentangle the different possible mechanisms of action underlying vaccine protection effects against TB, conditioned to trial design, size, and duration. Our results unlock a deeper interpretation of the data emanating from efficacy trials of TB vaccines, which renders them more interpretable in terms of transmission models and translates into explicit recommendations for vaccine developers.

SUBMITTER: Tovar M 

PROVIDER: S-EPMC6884451 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines.

Tovar Mario M   Arregui Sergio S   Marinova Dessislava D   Martín Carlos C   Sanz Joaquín J   Moreno Yamir Y  

Nature communications 20191129 1


In Tuberculosis (TB), given the complexity of its transmission dynamics, observations of reduced epidemiological risk associated with preventive interventions can be difficult to translate into mechanistic interpretations. Specifically, in clinical trials of vaccine efficacy, a readout of protection against TB disease can be mapped to multiple dynamical mechanisms, an issue that has been overlooked so far. Here, we describe this limitation and its effect on model-based evaluations of vaccine imp  ...[more]

Similar Datasets

| S-EPMC3409871 | biostudies-literature
| S-EPMC6792192 | biostudies-literature
| S-EPMC6494054 | biostudies-literature
| S-EPMC6592779 | biostudies-literature
| S-EPMC1287174 | biostudies-literature
| S-EPMC11000549 | biostudies-literature
| S-EPMC5445562 | biostudies-literature
| S-EPMC4217399 | biostudies-literature
| S-EPMC7908776 | biostudies-literature
| S-EPMC6210229 | biostudies-literature